ClearPoint Neuro (CLPT) EBITDA (2011 - 2026)
ClearPoint Neuro (CLPT) EBITDA from Mar 31, 2011 to Mar 31, 2026. The TTM ClearPoint Neuro (CLPT) EBITDA is -$26M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
ClearPoint Neuro (CLPT) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +23.18% |
| 3 Years TTM | +12.79% |
| 5 Years TTM | +30.05% |
| 10 Years TTM | +18.84% |
| All Time TTM | +12.43% |
Annual EBITDA change of ClearPoint Neuro (CLPT)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$8.39M | -64.07% |
| 2025 | -$23M | +24.53% |
| 2024 | -$19M | -14.07% |
| 2023 | -$22M | +35.61% |
| 2022 | -$16M | +21.80% |
| 2021 | -$13M | +124.28% |
| 2020 | -$5.89M | +32.36% |
| 2019 | -$4.45M | -13.42% |
| 2018 | -$5.14M | -17.36% |
| 2017 | -$6.22M | -15.14% |
| 2016 | -$7.33M | -16.32% |
| 2015 | -$8.76M | +77.33% |
| 2014 | -$4.94M | -29.93% |
| 2013 | -$7.05M | +160.15% |
| 2012 | -$2.71M | -51.35% |
| 2011 | -$5.57M | -39.78% |
| 2010 | -$9.25M | N/A |
Comparison ClearPoint Neuro (CLPT) five years EBITDA CAGR with competitors
ClearPoint Neuro (CLPT) five years EBITDA CAGR is 30.06%.